# DESCRIPTION

## TECHNICAL FIELD

- define technical field

## BACKGROUND

- describe viral hemorrhagic fever

## SUMMARY

- state technical problem
- introduce berbamine dihydrochloride
- describe use of berbamine dihydrochloride
- describe pharmaceutical compound
- describe method for inhibiting virus

## DETAILED DESCRIPTION

- introduce experimental methods and materials
- describe embodiments of the invention

### Embodiment 1. Verification of Berbamine Dihydrochloride being Capable of Specifically Inhibit the Activity of EBOV by Using a Screening Model for an EBOV Entry Inhibitor

- describe preparation of EBOV-Zaire GP/HIV-luc pseudovirus particles
- evaluate antiviral activity of berbamine dihydrochloride

### Embodiment 2: The Antiviral Activity of Berbamine Dihydrochloride Having Nothing to do with its Cytotoxicity

- evaluate cytotoxicity of berbamine dihydrochloride using CCK-8 kit

### Embodiment 3. Berbamine Dihydrochloride Having a Good Dose-Dependent Inhibition Effect on EBOV

- evaluate dose-dependent inhibition effect of berbamine dihydrochloride on EBOV

### Embodiment 4: Berbamine Dihydrochloride Acting on the Entering Stage of a Virus, as Determined by a Drug TOA Experiment

- study acting phase of berbamine dihydrochloride in virus infection cycle using drug TOA experiment

### Embodiment 5. Evaluation of Compounds Using Marburg Recombinant Virus and Lassa Recombinant Virus Models

- evaluate antiviral activity of berbamine dihydrochloride against Marburg virus and Lassa virus

### Embodiment 6. Determination of the Capability of Berbamine Dihydrochloride of Binding to the Target Protein GPcl In Vitro by Using a BioLayer Interferometry Technology

- determine binding capability using BLI technology
- generalize to other viruses and modifications

